Mobile

A Phase II Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre Study to determine the efficacy and dose response of repeat inhaled doses of GW870086X on FEV1 in adults with Persi...

Mise à jour : Il y a 5 ans
Référence : EUCTR2010-022279-77

A Phase II Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre Study to determine the efficacy and dose response of repeat inhaled doses of GW870086X on FEV1 in adults with Persistent Asthma

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To determine the efficacy and dose response of repeat inhaled doses of GW870086X once daily after 28 days on FEV1 in mild to moderate asthmatics, compared with placebo

Critère d'inclusion

  • Asthma

Liens